Cairo - Mubasher: Arab Drug Company achieved net profits of EGP 102 million in fiscal year (FY) 2020/2021, up by 9.9% year-on-year (YoY) from EGP 92.8 million, the unaudited financial results showed.
The revenues increased to EGP 537 million in the year ended 30 June, compared to EGP 521.07 million a year earlier, the company said in a bourse disclosure on Thursday.
During the first 11 months of FY20/21, Arab Drug Company achieved net profits before tax of EGP 122.2 million, up from EGP 112.68 million in the same period in FY19/20.
